Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Barchart Premier: The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | More
 
or
Watchlist | Portfolio
Site News
Contact
Market:

Merus N.V. CS (MRUS)

Merus N.V. CS (MRUS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
Pancreatic Cancer Battle Intensifies: Biotech Innovations Aim to Boost Survival Rates Newswire.ca - Thu May 23, 10:51AM CDT

/CNW/ -- USA News Group – Known as one of the deadliest cancers, researchers are working diligently to help increase the chance of survival for pancreatic...

ONCY : 1.0300 (unch)
CADL : 6.01 (-3.45%)
AZN : 78.71 (+0.83%)
MRUS : 55.29 (+0.88%)
LTRN : 4.41 (-1.56%)
ONC.TO : 1.41 (+0.71%)
Biotech Developers Pioneer New Treatments, Aiming to Reduce Pancreatic Cancer Fatalities in 2024 BayStreet.ca - Thu May 23, 8:32AM CDT

USA News Group – Known as one of the deadliest cancers, researchers are working diligently to help increase the chance of survival for pancreatic cancer patients through earlier detection, as according...

ONCY : 1.0300 (unch)
ONC.TO : 1.41 (+0.71%)
CADL : 6.01 (-3.45%)
AZN : 78.71 (+0.83%)
MRUS : 55.29 (+0.88%)
LTRN : 4.41 (-1.56%)
Pancreatic Cancer Battle Intensifies with Biotech Sector's Advanced Treatments BayStreet.ca - Fri May 17, 10:48AM CDT

USA News Group – A new study is bringing hope in the fight against one of the deadliest cancers, revealing a blood test that can detect early-stage pancreatic cancer with 97% accuracy. This breakthrough...

ONCY : 1.0300 (unch)
ONC.TO : 1.41 (+0.71%)
RHHBY : 39.2700 (-0.18%)
MRUS : 55.29 (+0.88%)
MGNX : 4.92 (-1.99%)
IMRX : 1.1100 (-2.63%)
New FDA Designations Accelerate Progress in Pancreatic Cancer Treatments: A Year in Review FinancialNewsMedia - Fri Oct 13, 2023

EQNX::TICKER_START (NASDAQ:ONCY),(TSX:ONC),(NASDAQ:PYXS),(NASDAQ:AZN),(NYSE:LLY),(NASDAQ:MRUS) EQNX::TICKER_END

ONCY : 1.0300 (unch)
ONC.TO : 1.41 (+0.71%)
PYXS : 3.48 (+7.41%)
AZN : 78.71 (+0.83%)
LLY : 857.47 (+1.01%)
MRUS : 55.29 (+0.88%)
New FDA Designations Accelerate Progress in Pancreatic Cancer Treatments: A Year in Review PR Newswire - Fri Oct 13, 2023

/PRNewswire/ -- USA News Group - Since September 2022, the US Food and Drug Administration (FDA) has seen new treatments for pancreatic cancer that are worthy...

ONC.TO : 1.41 (+0.71%)
ONCY : 1.0300 (unch)
PYXS : 3.48 (+7.41%)
AZN : 78.71 (+0.83%)
LLY : 857.47 (+1.01%)
MRUS : 55.29 (+0.88%)
Breakthroughs in Pancreatic Cancer Treatment: How FDA Designations are Changing the Game BayStreet.ca - Wed Oct 11, 2023

USA News Group – Since September 2022, the US Food and Drug Administration (FDA) has seen new treatments for pancreatic cancer that are worthy of further investigation or approval. Known as one of the...

ONCY : 1.0300 (unch)
ONC.TO : 1.41 (+0.71%)
PYXS : 3.48 (+7.41%)
AZN : 78.71 (+0.83%)
LLY : 857.47 (+1.01%)
MRUS : 55.29 (+0.88%)
Pancreatic Cancer Research Gains Momentum Amidst Soaring Young-Onset Cases PR Newswire - Tue Sep 26, 2023

/PRNewswire/ -- USA News Group - The seriousness of pancreatic cancer continues to grow, with increasing alarm since The Lancet published an analysis back in...

ONC.TO : 1.41 (+0.71%)
ONCY : 1.0300 (unch)
MRUS : 55.29 (+0.88%)
GH : 30.75 (-1.28%)
MDT : 79.48 (-2.13%)
NVDA : 117.93 (-2.61%)
Pancreatic Cancer Research Gains Momentum Amidst Soaring Young-Onset Cases FinancialNewsMedia - Tue Sep 26, 2023

FN Media Group Presents USA News Group News Commentary   Vancouver, BC – September 26, 2023 – USA News Group  –  The seriousness of pancreatic cancer continues to grow, with increasing alarm since...

ONCY : 1.0300 (unch)
ONC.TO : 1.41 (+0.71%)
MRUS : 55.29 (+0.88%)
GH : 30.75 (-1.28%)
MDT : 79.48 (-2.13%)
NVDA : 117.93 (-2.61%)
Pancreatic Cancer's Alarming Surge in Young Adults Sparks Research into New Treatments BayStreet.ca - Tue Sep 26, 2023

USA News Group – The seriousness of pancreatic cancer continues to grow, with increasing alarm since The Lancet published an analysis back in April 2023, showing a rising incidence of pancreatic cancer...

ONCY : 1.0300 (unch)
ONC.TO : 1.41 (+0.71%)
MRUS : 55.29 (+0.88%)
GH : 30.75 (-1.28%)
MDT : 79.48 (-2.13%)
NVDA : 117.93 (-2.61%)
Merus Announces Financial Results for the Second Quarter and Provides Business Update Globe Newswire - Mon Aug 8, 2022

- Clinical update of zenocutuzumab (Zeno) presented at the 2022 American Society of Clinical Oncology (ASCO) Annual Meeting - Zeno represents a potential...

MRUS : 55.29 (+0.88%)

Barchart Exclusives

Option Volatility And Earnings Report For July 22 - 26 Barchart - 14 minutes ago
This week we have Tesla (TSLA), Microsoft (MSFT), Alphabet (GOOGL), Exxon Mobil (XOM), Visa (V), Abbvie (ABBV) and Chipotle Mexican Grill (CMG) all set to report. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar

[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot